Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer (original) (raw)
National Cancer Institute. NCI Fact Book. Bethesda, Md: National Institutes of Health; 2003.
Brandau S and Bohle A (2001) Bladder cancer. I: Molecular and genetic basis of carcinogenesis. Eur Urol39: 491–497 CASPubMed Google Scholar
Feng Z et al. (2002) 4-aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene. Carcinogenesis23: 1721–1727 CASPubMed Google Scholar
Williams SG and Stein JP (2004) Molecular pathways in bladder cancer. Urol Res32: 373–385 PubMed Google Scholar
Tsutsumi M et al. (1998) Early acquisition of homozygous deletions of p16/p19 during squamous cell carcinogenesis and genetic mosaicism in bladder cancer. Oncogene17: 3021–3027 CASPubMed Google Scholar
Rieger-Christ KM et al. (2003) Identification of fibroblast growth factor receptor 3 mutations in urine sediment DNA samples complements cytology in bladder tumor detection. Cancer98: 737–744 CASPubMed Google Scholar
Dulaimi E et al. (2004) Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel. Clin Cancer Res10: 1887–1893 CASPubMed Google Scholar
Friedrich MG et al. (2004) Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Clin Cancer Res10: 7457–7465 CASPubMed Google Scholar
Markl ID and Jones PA (1998) Presence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer. Cancer Res58: 5348–5353 CASPubMed Google Scholar
Sarkar S et al. (2000) Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers. Cancer Res60: 3862–3871 CASPubMed Google Scholar
Dunn KL et al. (2005) The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling. Biochem Cell Biol83: 1–14 CASPubMed Google Scholar
Hipfner DR and Cohen SM (2004) Connecting proliferation and apoptosis in development and disease. Nat Rev Mol Cell Biol5: 805–815 CASPubMed Google Scholar
Billerey C et al. (2001) Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors. Am J Pathol158: 1955–1959 CASPubMedPubMed Central Google Scholar
Nicholson RI et al. (2001) EGFR and cancer prognosis. Eur J Cancer37 (Suppl 4): S9–S15 CASPubMed Google Scholar
Oxford G and Theodorescu D (2003) The role of Ras superfamily proteins in bladder cancer progression. J Urol170: 1987–1993 CASPubMed Google Scholar
Cappellen D et al. (1999) Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nat Genet23: 18–20 CASPubMed Google Scholar
Munro NP and Knowles MA (2003) Fibroblast growth factors and their receptors in transitional cell carcinoma. J Urol169: 675–682 CASPubMed Google Scholar
Jebar AH et al. (2005) FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma. Oncogene24: 5218–5225 CASPubMed Google Scholar
van Rhijn BW et al. (2002) Frequent FGFR3 mutations in urothelial papilloma. J Pathol198: 245–251 CASPubMed Google Scholar
Wallerand H et al. (2005) Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens. Carcinogenesis26: 177–184 CASPubMed Google Scholar
Bakkar AA et al. (2003) FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder. Cancer Res63: 8108–8112 CASPubMed Google Scholar
Cheng J et al. (2002) Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth. Cancer Res62: 4157–4163 CASPubMed Google Scholar
Zhang ZT et al. (2001) Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation. Oncogene20: 1973–1980 CASPubMed Google Scholar
Garcia-Espana A et al. (2005) Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior. Cancer Res65: 1150–1157 CASPubMed Google Scholar
Gao J et al. (2004) p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis. Oncogene23: 687–696 CASPubMed Google Scholar
Dimova DK and Dyson NJ (2005) The E2F transcriptional network: old acquaintances with new faces. Oncogene24: 2810–2826 CASPubMed Google Scholar
Oeggerli M et al. (2004) E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Oncogene23: 5616–5623 CASPubMed Google Scholar
Chen CH et al. (2005) Bidirectional signals transduced by DAPK-ERK interaction promote the apoptotic effect of DAPK. Embo J24: 294–304 CASPubMed Google Scholar
Tada Y et al. (2002) The association of death-associated protein kinase hypermethylation with early recurrence in superficial bladder cancers. Cancer Res62: 4048–4053 CASPubMed Google Scholar
Robertson KD et al. (2000) DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet25: 338–342 CASPubMed Google Scholar
Chatterjee SJ et al. (2004) Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer. J Pathol203: 762–770 CASPubMed Google Scholar
Cote RJ et al. (1998) Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res58: 1090–1094 CASPubMed Google Scholar
Batsche E et al. (1998) RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol Cell Biol18: 3647–3658 CASPubMedPubMed Central Google Scholar
Decesse JT et al. (2001) RB regulates transcription of the p21/WAF1/CIP1 gene. Oncogene20: 962–971 CASPubMed Google Scholar
Stein JP et al. (1998) Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer. J NatlCancer Inst90: 1072–1079 CAS Google Scholar
Wada T et al. (2000) Bladder cancer: allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and grade. Clin Cancer Res6: 610–615 CASPubMed Google Scholar
Eymin B et al. (2001) Human ARF binds E2F1 and inhibits its transcriptional activity. Oncogene20: 1033–1041 CASPubMed Google Scholar
Robertson KD and Jones PA (1998) The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol Cell Biol18: 6457–6473 CASPubMedPubMed Central Google Scholar
Hartmann A et al. (2002) Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder. Cancer Res62: 809–818 CASPubMed Google Scholar
Cheng J et al. (2003) Allelic loss of p53 gene is associated with genesis and maintenance, but not invasion, of mouse carcinoma in situ of the bladder. Cancer Res63: 179–185 CASPubMed Google Scholar
Swaminathan S et al. (2002) Human urinary bladder epithelial cells lacking wild-type p53 function are deficient in the repair of 4-aminobiphenyl-DNA adducts in genomic DNA. Mutat Res499: 103–117 CASPubMed Google Scholar
Spruck CH Jr et al. (1993) Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage. Cancer Res53: 1162–1166 CASPubMed Google Scholar
Orlow I et al. (1999) Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence. Am J Pathol155: 105–113 CASPubMedPubMed Central Google Scholar
Hartmann A et al. (1999) Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. Am J Pathol154: 721–727 CASPubMedPubMed Central Google Scholar
Chow NH et al. (2000) Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer. Int J Cancer89: 514–518 CASPubMed Google Scholar
Habuchi T et al. (1998) Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33. Genomics48: 277–288 CASPubMed Google Scholar
Nishiyama H et al. (2001) Negative regulation of G(1)/S transition by the candidate bladder tumour suppressor gene DBCCR1. Oncogene20: 2956–2964 CASPubMed Google Scholar
Wright KO et al. (2004) DBCCR1 mediates death in cultured bladder tumor cells. Oncogene23: 82–90 CASPubMed Google Scholar
Gonzalez-Zulueta M et al. (1995) Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res55: 4531–4535 CASPubMed Google Scholar
Jones PA and Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet3: 415–428 CASPubMed Google Scholar
Salem C et al. (2000) Progressive increases in de novo methylation of CpG islands in bladder cancer. Cancer Res60: 2473–2476 CASPubMed Google Scholar
Peterson EJ et al. (2003) p53-mediated repression of DNA methyltransferase 1 expression by specific DNA binding. Cancer Res63: 6579–6582 CASPubMed Google Scholar
McCabe MT et al. (2005) Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway. Cancer Res65: 3624–3632 CASPubMed Google Scholar
Ordway JM et al. (2004) Transcription repression in oncogenic transformation: common targets of epigenetic repression in cells transformed by Fos, Ras or Dnmt1. Oncogene23: 3737–3748 CASPubMed Google Scholar
Nakagawa T et al. (2005) DNA hypomethylation on pericentromeric satellite regions significantly correlates with loss of heterozygosity on chromosome 9 in urothelial carcinomas. J Urol173: 243–246 CASPubMed Google Scholar
Gonzalo S et al. (2005) Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat Cell Biol7: 420–428 CASPubMed Google Scholar
Kawamura K et al. (2004) Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression. Cancer Res64: 4800–4809 CASPubMed Google Scholar
van Tilborg AA et al. (2000) Molecular evolution of multiple recurrent cancers of the bladder. Hum Mol Genet9: 2973–2980 CASPubMed Google Scholar
Hopman AH et al. (2002) Identification of chromosome 9 alterations and p53 accumulation in isolated carcinoma in situ of the urinary bladder versus carcinoma in situ associated with carcinoma. Am J Pathol161: 1119–1125 CASPubMedPubMed Central Google Scholar
Stoehr R et al. (2004) Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer. Lab Invest84: 465–478 CASPubMed Google Scholar
Dyrskjot L et al. (2004) Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res64: 4040–4048 CASPubMed Google Scholar
Dyrskjot L et al. (2003) Identifying distinct classes of bladder carcinoma using microarrays. Nat Genet33: 90–96 CASPubMed Google Scholar
Knowles MA (1999) The genetics of transitional cell carcinoma: progress and potential clinical application. BJU Int84: 412–427 CASPubMed Google Scholar
Bartkova J et al. (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature434: 864–87055 CASPubMed Google Scholar